http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019035679-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80cbc9fc3a4bde51deab18978496c91b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcdf603c9b0857665caebdda0ddebc81 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb67ad4e161eb4f6caa900cd2e5f492 |
| publicationDate | 2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019035679-A2 |
| titleOfInvention | MICROPARTICLES COMPRISING FINASTERIDE, AND PROCESS FOR PRODUCING THE SAME |
| abstract | The present invention relates to microparticles comprising finasteride and a biodegradable polymer, the microparticles being present in the form of spherical biodegradable polymer particles comprising the finasteride drug uniformly distributed therein, and the average particle diameter of the microparticles being 20 to 70 μm. . The present invention relates to sustained-release microparticles, wherein the microparticles comprising finasteride can be administered to continuously maintain a hair loss treatment effect for 1 to 3 months; and their production process. In addition, the present invention includes administering the microparticles comprising finasteride to a patient via injections, and thus, in contrast to oral formulations, does not need to be stored or manipulated by the patient directly. Therefore, storage and handling are convenient. The pharmaceutical effect of the microparticles is maintained for a long period of 1 to 3 months, and the microparticles are produced so as to have a uniform average particle diameter and micrometer. Therefore, when administering the microparticles to a patient by injection, the irritation and pain are reduced, and thus the microparticles can be easily administered by injection. |
| priorityDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.